Anthony Hunt - Jul 21, 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Executive Officer, Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Jul 21, 2022
Transactions value $
-$4,300,060
Form type
4
Date filed
7/22/2022, 04:25 PM
Previous filing
Jun 17, 2022
Next filing
Sep 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $169K +5K +2.51% $33.87* 204K Jul 21, 2022 Direct
transaction RGEN Common Stock Options Exercise $491K +15.2K +7.42% $32.40* 219K Jul 21, 2022 Direct
transaction RGEN Common Stock Sale -$4.96M -24.8K -11.3% $200.00 195K Jul 21, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +5K +7.78% $0.00 69.2K Jul 21, 2022 Common Stock 5K $33.87 Direct F2
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +15.2K $0.00* 0 Jul 21, 2022 Common Stock 15.2K $32.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.
F2 This option is fully vested and exercisable.